Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Brugières, P. Quartier, M. Deley, H. Pacquement, Y. Pérel, C. Bergeron, C. Schmitt, J. Landmann, C. Patte, M. Terrier-Lacombe, G. Delsol, O. Hartmann (2000)Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.
Annals of oncology : official journal of the European Society for Medical Oncology, 11 1
E. Jaffe (2003)Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
A. Reiter, M. Schrappe, M. Tiemann, W. Ludwig, E. Yakisan, M. Zimmermann, G. Mann, A. Chott, W. Ebell, T. Klingebiel, N. Graf, B. Kremens, Stefan Müller-Weihrich, H. Plüss, F. Zintl, G. Henze, H. Riehm (1999)Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood, 94 10
J. Sandlund, James Downing, William Crist (1996)Non-Hodgkin's lymphoma in childhood.
The New England journal of medicine, 334 19
RJ Biggar, M Frisch, JJ Goedert (2000)Risk of cancer in children with AIDS
AIDS-Cancer Match Registry Study Group. JAMA, 284
T. Robak, E. Lech-Maranda, A. Korycka, E. Robak (2006)Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Current medicinal chemistry, 13 26
I. Magrath (1987)Malignant non-Hodgkin's lymphomas in children.
Hematology/oncology clinics of North America, 1 4
P. Houghton, C. Morton, E. Kolb, R. Lock, H. Carol, C. Reynolds, N. Keshelava, J. Maris, S. Keir, Jianrong Wu, Malcolm Smith (2008)Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
Pediatric Blood & Cancer, 50
A. Taylor, JA Metcalfe, J. Thick, YF Mak (1996)Leukemia and lymphoma in ataxia telangiectasia.
Blood, 87 2
Akiko Muto, A. Nakagawa, Yasuhito Shimomura, Yoshiro Kitagawa, M. Tsurusawa (2005)Antineoplastic agents for pediatric anaplastic large cell lymphoma: Vinblastine is the most effective in vitro
Leukemia & Lymphoma, 46
L. Ries, Malcolm Smith, J. Gurney, M. Linet, T. Tamra, John Young, G. Bunin (1999)Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995.
J. Adams, M. Kauffman (2004)Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Cancer Investigation, 22
Xiayuan Liang, S. Meech, L. Odom, M. Bitter, J. Ryder, S. Hunger, M. Lovell, L. Meltesen, Q. Wei, S. Williams, R. Hutchinson, L. Mcgavran (2004)Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
American journal of clinical pathology, 121 4
F. Montravers, D. McNamara, J. Landman-Parker, D. Grahek, K. Kerrou, N. Younsi, M. Wioland, G. Leverger, J. Talbot (2002)[18F]FDG in childhood lymphoma: clinical utility and impact on management
European Journal of Nuclear Medicine and Molecular Imaging, 29
謙 大間知 (2004)CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.Coiffier B,et al.N Engl J Med 2002;346(4):235-42--CHOP+リツキシマブ併用療法は、CHOP療法を上回る治療法であり、DLBCLの治療動向に大きなimpactを与えた
G Jerusalem, Y Beguin, MF Fassotte (1999)Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin?s disease and non-Hodgkin?s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
M. Granovsky, B. Mueller, H. Nicholson, P. Rosenberg, C. Rabkin (1998)Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 5
Ren-Yuan Bai, Ou Tao, C. Miething, S. Morris, C. Peschel, J. Duyster (2000)Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway.
Blood, 96 13
N. Wollner (1976)Non-Hodgkin's lymphoma in children.
Pediatric clinics of North America, 23 2
M. Lones, S. Perkins, R. Sposto, M. Kadin, C. Kjeldsberg, J. Wilson, M. Cairo (2000)Large-cell lymphoma arising in the mediastinum in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 22
M. Sasaki, Y. Kuwabara, H. Koga, M. Nakagawa, Tao Chen, Kouichirou Kaneko, Kazutaka Hayashi, Katsumasa Nakamura, K. Masuda (2002)Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma
Annals of Nuclear Medicine, 16
E. Raetz, M. Borowitz, M. Devidas, S. Linda, S. Hunger, N. Winick, B. Camitta, P. Gaynon, W. Carroll (2008)Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 24
G. Gaidano, A. Carbone, R. Dalla-Favera (1998)Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis.
Journal of the National Cancer Institute. Monographs, 23
R. Biggar, M. Frisch, J. Goedert (2000)Risk of Cancer in Children With AIDS
C. Patte, A. Aupérin, J. Michon, H. Behrendt, G. Leverger, D. Frappaz, P. Lutz, C. Coze, Y. Pérel, M. Raphael, M. Terrier-Lacombe (2001)The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Blood, 97 11
A. Ashkenazi, R. Pai, S. Fong, Susan Leung, David Lawrence, S. Marsters, Christine Blackie, Ling Chang, Amy McMurtrey, Andrea Hebert, L. Deforge, I. Koumenis, D. Lewis, Louise Harris, J. Bussiere, H. Koeppen, Z. Shahrokh, R. Schwall (1999)Safety and antitumor activity of recombinant soluble Apo2 ligand.
The Journal of clinical investigation, 104 2
D. Hossfeld (2002)E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
Annals of Oncology, 13
M. Ladanyi (1997)The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
Cancer surveys, 30
M. Cohen, John Johnson, T. Massie, R. Sridhara, W. Mcguinn, S. Abraham, B. Booth, M. Goheer, D. Morse, X. Chen, Nallaperumal Chidambaram, L. Kenna, J. Gobburu, R. Justice, R. Pazdur (2006)Approval Summary: Nelarabine for the Treatment of T-Cell Lymphoblastic Leukemia/Lymphoma
Clinical Cancer Research, 12
A. Reiter, M. Schrappe, W. Ludwig, M. Tiemann, R. Parwaresch, M. Zimmermann, E. Schirg, G. Henze, G. Schellong, H. Gadner, H. Riehm (2000)Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood, 95 2
J. Cortes, Deborah Thomas, C. Koller, F. Giles, E. Estey, S. Faderl, G. Garcia-Manero, D. McConkey, G. Patel, R. Guerciolini, J. Wright, H. Kantarjian (2004)Phase I Study of Bortezomib in Refractory or Relapsed Acute Leukemias
Clinical Cancer Research, 10
C. Bellan, S. Lazzi, G. Falco, A. Nyongo, Antonio Giordano, L. Leoncini (2003)Burkitt’s lymphoma: new insights into molecular pathogenesis
Journal of Clinical Pathology, 56
C. Patte, C. Kalifa, F. Flamant, O. Hartmann, L. Brugières, D. Valteau‐Couanet, C. Bayle, J. Caillaud, J. Lemerle (1992)Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.
Medical and pediatric oncology, 20 2
Malcolm Smith, C. Morton, E. Kolb, R. Gorlick, S. Keir, H. Carol, R. Lock, Min Kang, C. Reynolds, J. Maris, Amy Watkins, P. Houghton (2009)Initial testing (stage 1) of mapatumumab (HGS‐ETR1) by the pediatric preclinical testing program
Pediatric Blood & Cancer, 54
(2005)Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92
R. Biggar, M. Frisch, J. Goedert (2000)Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group.
JAMA, 284 2
L. Pukac, P. Kanakaraj, R. Humphreys, R. Alderson, M. Bloom, C. Sung, T. Riccobene, R. Johnson, M. Fiscella, Angela Mahoney, J. Carrell, Ernest Boyd, X. Yao, Linyi Zhang, L. Zhong, A. Kerczek, Lindsey Shepard, T. Vaughan, B. Edwards, C. Dobson, T. Salcedo, V. Albert (2005)HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo
British Journal of Cancer, 92
A. Meadows, R. Sposto, R. Jenkin, J. Kersey, R. Chilcote, S. Siegel, P. Coccia, J. Rosenstock, K. Pringle, C. Stolar (1989)Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 7 1
K. Savage, S. Monti, J. Kutok, G. Cattoretti, D. Neuberg, L. Leval, P. Kurtin, P. Cin, C. Ladd, F. Feuerhake, R. Aguiar, Sigui Li, G. Salles, F. Berger, Wen Jing, G. Pinkus, T. Habermann, R. Dalla-Favera, N. Harris, J. Aster, T. Golub, M. Shipp (2003)The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Blood, 102 12
L. Brugières, M. Deley, H. Pacquement, Z. Meguerian-Bedoyan, M. Terrier-Lacombe, A. Robert, C. Pondarré, G. Leverger, C. Devalck, C. Rodary, G. Delsol, O. Hartmann (1998)CD30(+) anaplastic large-cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology.
Blood, 92 10
J. Cusack, Rong Liu, M. Houston, Karin Abendroth, P. Elliott, J. Adams, A. Baldwin (2001)Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition.
Cancer research, 61 9
K. Seidemann, M. Tiemann, M. Schrappe, E. Yakisan, I. Simonitsch, G. Janka-Schaub, W. Dörffel, M. Zimmermann, G. Mann, H. Gadner, R. Parwaresch, H. Riehm, A. Reiter (2001)Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood, 97 12
C. Mullighan, Jinghui Zhang, R. Harvey, J. Collins-Underwood, B. Schulman, Letha Phillips, S. Tasian, M. Loh, X. Su, Wei Liu, M. Devidas, S. Atlas, I. Chen, R. Clifford, D. Gerhard, W. Carroll, G. Reaman, Malcolm Smith, J. Downing, S. Hunger, C. Willman (2009)JAK mutations in high-risk childhood acute lymphoblastic leukemia
Proceedings of the National Academy of Sciences, 106
G. Depas, C. Barsy, G. Jerusalem, C. Hoyoux, M. Dresse, M. Fassotte, N. Paquet, J. Foidart, P. Rigo, R. Hustinx (2004)18F-FDG PET in children with lymphomas
European Journal of Nuclear Medicine and Molecular Imaging, 32
J Mora, DA Filippa, J Qin, N Wollner (2003)Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial Sloan-Kettering Cancer Center
O. Neth, K. Seidemann, Petra Jansen, G. Mann, M. Tiemann, W. Ludwig, Hansj�rg Riehm, A. Reiter (2000)Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL-BFM 86 and 90.
Medical and pediatric oncology, 35 1
H. Ruchatz, A. Coluccia, P. Stano, E. Marchesi, C. Gambacorti-Passerini (2003)Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells.
Experimental hematology, 31 4
(2003)Results of a randomized FAB LMB96 international study in children and adolescents (C + A) with advanced B-NHL: Pts with L3 leukemia/CNS- have an excellent prognosis
M. Cairo, E. Raetz, M. Lim, V. Davenport, S. Perkins (2005)Childhood and adolescent non‐Hodgkin lymphoma: New insights in biology and critical challenges for the future
Pediatric Blood & Cancer, 45
Weisheng Xu, R. Parmigiani, PA Marks (2007)Histone deacetylase inhibitors: molecular mechanisms of action
K. Spaepen, S. Stroobants, P. Dupont, S. Steenweghen, J. Thomas, P. Vandenberghe, L. Vanuytsel, G. Bormans, J. Balzarini, C. Wolf-Peeters, L. Mortelmans, G. Verhoef (2001)Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 2
M. Allen-Auerbach, A. Quon, W. Weber, S. Obrzut, Tyler Crawford, D. Silverman, O. Ratib, M. Phelps, J. Czernin (2004)Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, 6 6
J. Mora, D. Filippa, J. Qin, N. Wollner (2003)Lymphoblastic lymphoma of childhood and the LSA2‐L2 protocol
M. Vries, A. Veerman, C. Zwaan (2004)Rituximab in three children with relapsed/refractory B‐cell acute lymphoblastic leukaemia/Burkitt non‐Hodgkin's lymphoma
British Journal of Haematology, 125
R. Ponzielli, Sigal Katz, D. Barsyte-Lovejoy, L. Penn (2005)Cancer therapeutics: targeting the dark side of Myc.
European journal of cancer, 41 16
C. Cinti, P. Claudio, C. Howard, L. Neri, Yan Fu, L. Leoncini, G. Tosi, N. Maraldi, A. Giordano (2000)Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.
Cancer research, 60 2
M. Link, J. Shuster, S. Donaldson, C. Berard, S. Murphy (1997)Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
The New England journal of medicine, 337 18
N Wollner, JH Burchenal, PH Lieberman (1975)Non-Hodgkin?s lymphoma in children
Med Pediatr Oncol, 1
L. Herrera, B. Bostrom, L. Gore, E. Sandler, Glen Lew, P. Schlegel, V. Aquino, V. Ghetie, E. Vitetta, J. Schindler (2009)A Phase 1 Study of Combotox in Pediatric Patients With Refractory B-lineage Acute Lymphoblastic Leukemia
Journal of Pediatric Hematology/Oncology, 31
K. Sullivan, C. Mullen, R. Blaese, J. Winkelstein (1994)A multiinstitutional survey of the Wiskott-Aldrich syndrome.
The Journal of pediatrics, 125 6 Pt 1
B. Coiffier, É. Lepage, J. Brière, R. Herbrecht, H. Tilly, R. Bouabdallah, P. Morel, E. Neste, G. Salles, P. Gaulard, F. Reyes, P. Lederlin, C. Gisselbrecht (2002)CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
The New England journal of medicine, 346 4
M. LaQuaglia, C. Stolar, M. Krailo, P. Exelby, S. Siegel, A. Meadows, D. Hammond (1992)The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group.
Journal of pediatric surgery, 27 2
Shimareet Kumar, S. Pittaluga, M. Raffeld, M. Guerrera, N. Seibel, E. Jaffe (2005)Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma in Childhood: Report of 4 Cases and Review of the Literature
Pediatric and Developmental Pathology, 8
M. Cairo, R. Sposto, S. Perkins, A. Meadows, Margo Hoover-Regan, James Anderson, S. Siegel, M. Lones, Nicole Tedeschi-Blok, M. Kadin, C. Kjeldsberg, John Wilson, W. Sanger, E. Morris, M. Krailo, J. Finlay (2003)Burkitt's and Burkitt‐like lymphoma in children and adolescents: a review of the Children's Cancer Group Experience *
British Journal of Haematology, 120
F. Gumy-Pause, P. Wacker, A. Sappino (2004)ATM gene and lymphoid malignancies
P. Pizzo, D. Poplack (1989)Principles and Practice of Pediatric Oncology
M. Cairo, R. Sposto, Margo Hoover-Regan, A. Meadows, James Anderson, S. Siegel, M. Kadin, C. Kjeldsberg, John Wilson, S. Perkins, M. Lones, E. Morris, J. Finlay (2003)Childhood and adolescent large‐cell lymphoma (LCL): A review of the children's cancer group experience
American Journal of Hematology, 72
R. Goldsby, W. Carroll (1998)The Molecular Biology of Pediatric Lymphomas
Journal of Pediatric Hematology/Oncology, 20
Lymphomas represent the third most common cancer in children and adolescents. The non-Hodgkin’s lymphomas comprise a heterogeneous group of tumors, with distinct clinical and pathologic features. Although intensive multi-agent chemotherapy has made non-Hodgkin’s lymphoma one of the most curable malignancies in children and young adults, there is room for improvement in treatment, particularly for those with advanced-stage disease and those who relapse after conventional therapy. New approaches are now attempting to reduce the burden of treatment, to focus on novel and more specific biologic targets, and to improve outcomes for patients with advanced-stage disease while reducing the potential for late effects. A comprehensive review of all potential agents is beyond the scope of this review, which will focus on some of the newer strategies for treating non-Hodgkin’s lymphoma that are coming into clinical use today.
Current Hematologic Malignancy Reports – Springer Journals
Published: Jul 17, 2010
Access the full text.
Sign up today, get DeepDyve free for 14 days.